The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis
Abstract
Background Anxiety disorders (AD) are common mental disorders, for which several cost-of-illness (COI) studies have been conducted in the past. Objective The aim of this review was to provide a systematic overview of these studies and an aggregation of their results. Methods A systematic literature search limited to studies published after 1999 was conducted in PubMed/MEDLINE in November 2018. We included top-down COI studies reporting costs for AD, and bottom-up COI studies reporting costs for AD and a non-diseased control group, and extracted data manually. Results of the top-down COI studies were aggregated by calculating the mean percentage of costs on gross domestic product (GDP) and health expenditure, while the results of the bottom-up studies were analyzed meta-analytically using the 'ratio of means' method and inverse-variance pooling. In this review, the logarithm of the relative difference in a continuous outcome between two groups is calculated and aggregated over the studies. The results can be interpreted as the relative change in costs imposed by a specific disease compared with baseline costs. Results We identified 13 top-down and 11 bottom-up COI studies. All top-down COI studies and four bottom-up COI studies reported costs for AD as a diagnostic group, four for generalized anxiety disorder (GAD), four for social anxiety disorder (SAD), and one for panic disorder. In top-down COI studies, direct costs of AD, on average, corresponded to 2.08% of health care c…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Epidemiology of anxiety disorders in the 21st century
Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079
Cost of disorders of the brain in Europe 2010
Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.008 · Cited by 1,723
The economic burden of anxiety disorders in the 1990s
Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0702 · Cited by 1,242
Friedrich, J. O., Adhikari, N. K. J., & Beyene, J. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-32 · Cited by 333
The size, burden and cost of disorders of the brain in the UK
Fineberg, N. A., Haddad, P. M., Carpenter, L., Gannon, B., Sharpe, R., Young, A. H., Joyce, E. M., Rowe, J. B., Wellsted, D. M., Nutt, D., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113495118 · Cited by 232
The economic consequences of social phobia
Patel, A. K., Knapp, M. R. J., Henderson, J., & Baldwin, D. S. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00323-2 · Cited by 192
Vasiliadis, H., Dionne, P.-A., Préville, M., Gentil, L., Berbiche, D., & Latimer, E. A. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.12.016 · Cited by 140
Economic costs of social phobia: A population-based study
Acartürk, C., Smit, F., de Graaf, R., van Straten, A., ten Have, M., & Cuijpers, P. J. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.008 · Cited by 125
Medical and productivity costs of anxiety disorders: Case control study
Marciniak, M., Lage, M. J., Landbloom, R. P., Dunayevich, E., & Bowman, L. (2004) · Depression and Anxiety · doi:10.1002/da.10131 · Cited by 99
Cost of anxiety disorders in Japan in 2008: a prevalence-based approach
Sado, M., Takechi, S., Inagaki, A., Fujisawa, D., Koreki, A., Mimura, M., & Yoshimura, K. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-338 · Cited by 92
CONCEPTUALIZATIONS OF THE SOCIETAL PERSPECTIVE WITHIN ECONOMIC EVALUATIONS: A SYSTEMATIC REVIEW
Drost, R. M. W. A., van der Putten, I. M., Ruwaard, D., Evers, S., & Paulus, A. T. G. (2017) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462317000526 · Cited by 77
Generalized anxiety disorder, somatic pain and health care costs
Olfson, M., & Gameroff, M. J. (2007) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.04.004 · Cited by 75
Shirneshan, E., Bailey, J., Relyea, G. E., Franklin, B. E., Solomon, D. K., & Brown, L. M. (2013) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2013.09.009 · Cited by 59
Medical Utilisation and Costs in Panic Disorder
Rees, C. S., Richards, J. C., & Smith, L. M. (1998) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(98)00026-7 · Cited by 49
Friedrich, J. O., Adhikari, N. K. J., & Beyene, J. (2012) · Statistics in Medicine · doi:10.1002/sim.4501 · Cited by 47
Excess costs of social anxiety disorder in Germany
Dams, J., König, H., Bleibler, F., Hoyer, J., Wiltink, J., Beutel, M. E., Salzer, S., Herpertz, S., Willutzki, U., Strauss, B. M., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.01.041 · Cited by 38
Self-citationThe Cost of Generalized Anxiety Disorder in Primary Care Settings: Results of the ANCORA Study
Rovira, J., Albarracin, G., Salvador‐Carulla, L., Rejas, J., Sánchez, E., & Hita, J. M. C. (2012) · Community Mental Health Journal · doi:10.1007/s10597-012-9503-4 · Cited by 37
Rutledge, T., Kenkre, T. S., Bittner, V., Krantz, D. S., Thompson, D. V., Linke, S., Eastwood, J., Eteiba, W., Cornell, C. E., Vaccarino, V., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.036 · Cited by 37
Cost of disorders of the brain in Italy
Pugliatti, M., Sobocki, P., Beghi, E., Pini, S., Cassano, G. B., Altamura, A. C., Pozzoli, S. M., & Rosati, G. (2008) · Neurological Sciences · doi:10.1007/s10072-008-0868-7 · Cited by 30
DiBonaventura, M., Toghanian, S., Järbrink, K., & Locklear, J. C. (2014) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s55429 · Cited by 29
Cost of disorders of the brain in Norway
Stovner, L. J., Gjerstad, L., Gilhus, N. E., Storstein, A. M., & Zwart, J.-A. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01367.x · Cited by 22
Huang, C., Chiu, H., Hsieh, H., Yen, J., Lee, M., Chang, K., Li, C.-Y., & Lin, C. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.04.008 · Cited by 21
Die Kosten von "Gehirnerkrankungen" in Österreich im Jahr 2004
Wancata, J., Andlin‐Sobocki, P., & Katschnig, H. (2007) · Wiener klinische Wochenschrift · doi:10.1007/s00508-006-0725-8 · Cited by 20
Costs of brain disorders in Finland
Sillanpää, M. L., Andlin‐Sobocki, P., & Lönnqvist, J. K. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00973.x · Cited by 20
Cost of disorders of the brain in Denmark
Olesen, J., Sobscki, P., Truelsen, T. C., Sestoft, D., & Jönsson, B. (2008) · Nordic Journal of Psychiatry · doi:10.1080/08039480801979792 · Cited by 18
Maercker, A. R. A., Perkonigg, A., Preisig, M., Schaller, K., Weller, M., & Cost, O. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2013.13751 · Cited by 17
Cost estimates of brain disorders in Belgium.
Schoenen, J. E., Franco, G., Schretlen, L., & Sobocki, P. (2006) · PubMed · Cited by 13
Economic costs of anxiety disorders
DuPont, R. L., Rice, D. P., Miller, L. S., Shiraki, S. S., Rowland, C. R., & Harwood, H. J. (1996) · Anxiety · doi:10.1002/(sici)1522-7154(1996)2:4
Cited by
Sorted by citations
Hohls, J. K., König, H.-H., Quirke, E., & Hajek, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182212022 · Cited by 296
Self-citationFatoye, F., Gebrye, T., Ryan, C. G., Useh, U., & Mbada, C. E. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1098100 · Cited by 169
Chodavadia, P. A., Teo, I., Poremski, D., Fung, D. S. S., & Finkelstein, E. A. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04581-7 · Cited by 160
Understanding clinical fear and anxiety through the lens of human fear conditioning
Beckers, T., Hermans, D., Lange, I., Luyten, L., Scheveneels, S., & Vervliet, B. (2023) · Nature Reviews Psychology · doi:10.1038/s44159-023-00156-1 · Cited by 178
Correlates of Quality of Life in Anxiety Disorders: Review of Recent Research
Wilmer, M. T., Anderson, K., & Reynolds, M. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01290-4 · Cited by 150
Metadata
- Authors
- Konnopka, A., & König, H.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- Konnopka, Alexander
- Venue
- PharmacoEconomics
- Published
- 2019-10-24
- Volume
- 38
- Issue
- 1
- Pages
- 25-37
- ISSN
- 1170-7690 (ISSN-L)
- 1179-2027
- OpenAlex
- W2981592857
- Cited by
- 259
- References
- 30
- Citations by year
- 2026: 38 · 2025: 48 · 2024: 50 · 2023: 48 · 2022: 40 · 2021: 25 · 2020: 8 · 2019: 1
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PharmacoEconomics (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- anxiety disorders, economic burden, direct costs, indirect costs, generalized anxiety disorder, social anxiety disorder, panic disorder, health care costs, productivity loss, gross domestic product, study heterogeneity, subgroup analysis, mental health policy, mental health professionals, mental health service utilization
- MeSH terms
- Anxiety Disorders, Health Expenditures, Humans, Health Care Costs, Cost of Illness, Gross Domestic Product
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
